P267 Dlco predicts disease severity and mortality in bronchiectasis We sought to examine the relationship between DLCO% and clinical and radiological variables in a well-defined population of bronchiectasis patients to determine its potential prognostic significance and compare with FEV1%
Lung diffusing capacity in adult bronchiectasis: a . . . - PubMed Interstitial lung disease is also a feature of bronchiectasis, but whether this is associated with a decline in lung diffusing capacity (measured as the diffusing capacity of the lung for carbon monoxide [D (LCO)]) is not well known
A comprehensive approach to lung function in bronchiectasis Standard operating procedures for the outpatient care of bronchiectasis patients in both centers included the assessment of body-plethysmography before and after the bronchodilation test, together with DLCO
DLCO predicts disease severity and mortality in patients with non . . . Conclusion: DLCO may be a significant predictor of radiological disease extent, disease severity and mortality in BR patients Background: Few studies have assessed the role of lung diffusing capacity (diffusing capacity of the lung for carbon monoxide (DLCO)) in non-CF bronchiectasis (BR)
Lung Diffusion Testing (DLCO): Purpose, Range Results Lung diffusion testing (DLCO) is a safe, noninvasive way for your healthcare provider to get important information about how well your lungs are working They can use it to help diagnose conditions, to evaluate how well treatments are working and to clear you for surgery
P267 Dlco predicts disease severity and mortality in bronchiectasis DLCO% predicts radiological disease, disease severity and mortality in bronchiectasis, independently of aetiology, and may identify patients with advanced disease who could benefit from intensive management